• Latest – submit your abstract now


Professor John Maher

Consultant in Immunology

King's College London


Dr John Maher is a clinical immunologist and immunopathologist who leads the “CAR Mechanics” research group within King’s College London. He played a key role in the early development of second generation CAR technology at Memorial Sloan Kettering Cancer Center – an advance which has achieved marked clinical impact in B-cell malignancy. His research group is focused on the development of adoptive immunotherapy using CAR engineered and gamma delta T-cells, with a primary focus on solid tumours. He is chief investigator of a Phase 1 CAR T-cell clinical trial in head and neck cancer and is also chief scientific officer of a spin-out company named Leucid Bio. In addition, he is a consultant immunologist within King’s Health Partners and Eastbourne Hospital.